Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Raia Drogasil S.A. is Brazil’s largest pharmacy retail company, operating in the pharmaceutical retail and health & wellness sectors. The company focuses on the sale of prescription and over-the-counter medicines, personal care products, beauty items, and convenience goods through an extensive network of drugstores. Its core revenue drivers are prescription drugs, non-prescription medicines, and front-of-store consumer health and beauty products, complemented by private-label offerings and digital sales channels.
The company operates under the well-known banners Raia and Drogasil, which together form a dominant national brand portfolio with strong consumer recognition. Raia Drogasil serves individual consumers across income segments, with a strategic emphasis on scale, operational efficiency, and proximity-based retail. The company was formed in 2011 through the merger of Droga Raia and Drogasil, two of Brazil’s oldest pharmacy chains, creating a market leader that has since expanded aggressively through organic store openings rather than large-scale acquisitions.
Business Operations
Raia Drogasil operates a single, integrated pharmacy retail business model, with revenues generated primarily from in-store and digital sales of pharmaceuticals and health-related consumer products. Its operations include prescription fulfillment, consumer health retail, and omnichannel services such as e-commerce, mobile applications, and home delivery. The company controls centralized distribution centers, proprietary logistics systems, and in-house digital platforms that support inventory management and last-mile delivery.
The company’s operations are predominantly domestic, with nearly all revenues generated in Brazil. Key operational assets include its nationwide store network, private-label product lines, loyalty programs, and digital health services. Raia Drogasil does not rely on franchising and operates company-owned stores exclusively, which allows for standardized execution, pricing discipline, and consistent customer experience across locations.
Strategic Position & Investments
Raia Drogasil’s strategy centers on disciplined organic growth, productivity gains, and digital integration. The company consistently invests in new store openings, modernization of existing locations, and technology aimed at improving customer engagement and operational efficiency. Digital sales, omnichannel fulfillment, and data-driven customer relationship management are key strategic priorities, supporting both revenue growth and margin optimization.
In addition to its core retail focus, the company invests selectively in health-related services and digital health initiatives, including medication adherence tools and health data platforms integrated into its customer ecosystem. While acquisitions are not a primary growth lever, Raia Drogasil has made targeted investments in technology and innovation to reinforce its leadership position in Brazil’s pharmacy retail sector. Data inconclusive based on available public sources regarding material equity investments outside its core operations.
Geographic Footprint
Raia Drogasil operates exclusively in Brazil, with a presence across all major regions, including the Southeast, South, Northeast, Central-West, and North. The company’s headquarters are located in São Paulo, which also represents its largest and most strategically important market. Its dense urban store footprint provides competitive advantages in convenience, logistics efficiency, and brand visibility.
While the company does not operate stores outside Brazil, its scale gives it significant influence within the Latin American pharmacy retail landscape. International exposure is limited to capital markets access, as its shares trade on Brazil’s B3 exchange and through American Depositary Receipts in the United States, but operational activities remain fully domestic.
Leadership & Governance
Raia Drogasil is led by an experienced executive team with long tenure in Brazilian retail and healthcare services. The company emphasizes decentralized store operations combined with centralized strategic planning, focusing on long-term value creation, operational excellence, and corporate governance aligned with public-market standards. Its leadership philosophy prioritizes sustainable growth, capital discipline, and customer-centric innovation.
Key executives include:
- Sergio Barreto – Chief Executive Officer
- Marcelo Pimentel – Vice Chairman of the Board
- Fabiano Contarato – Chief Financial Officer
- Ricardo Inglez de Souza – Chief Operating Officer
- Vivian Wolff – Chief Digital and Customer Officer
The company maintains a professional management structure with separation between executive management and board oversight, consistent with governance practices expected of large publicly listed Brazilian companies.